首页|急性缺血性脑卒中血管内治疗后造影剂外渗的研究进展

急性缺血性脑卒中血管内治疗后造影剂外渗的研究进展

扫码查看
脑卒中是目前导致人类致死、致残的主要疾病。脑卒中的发病率、死亡率随着年龄增长而增高,随着我国人口老龄化的加剧,脑卒中给我国患者、家庭、社会带来沉重的负担。在全部卒中类型中,急性缺血性脑卒中占70%~80%,而血管内治疗已经成为急性缺血性卒中患者的主要治疗方法。但治疗中可能发生的造影剂外渗已成为较常见现象,临床上识别造影剂渗出及预测渗出对患者临床预后的影响非常重要。现就急性缺血性脑卒中血管内治疗后发生造影剂外渗的原因、危险因素、临床预后做一综述。
Research progress of contrast agent extravasation after endovascular treatment of acute ischemic stroke
Stroke is the leading cause of death and disability in humans.The incidence and mortality of stroke increase with age.With the aggravation of population aging in China,stroke brings heavy burden to pa-tients,families and society.Among all types of stroke,acute ischemic stroke accounts for 70%-80%,and en-dovascular treatment has become the main treatment for patients with acute ischemic stroke.However,con-trast agent extravasation that may occur during treatment has become a common phenomenon.It is very im-portant to clinically identify contrast agent extravasation and predict the effect of extravasation on the clinical prognosis of patients.This article reviewed the causes,risk factors and clinical prognosis of contrast agent ex-travasation after endovascular treatment of acute ischemic stroke.

Acute ischemic strokeEndovascular treatmentContrast agent extravasationReview

杨鑫宇、李浩

展开 >

成都中医药大学医学与生命科学学院,四川成都 610000

宜宾市第一人民医院神经内科,四川 宜宾 644000

急性缺血性脑卒中 血管内治疗 造影剂外渗 综述

四川省医学科研课题计划项目

S19056

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(13)